+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Platinum anticancer drugs and photochemotherapeutic agents: recent advances and future developments

Platinum anticancer drugs and photochemotherapeutic agents: recent advances and future developments

Science Progress 97(Pt 1): 20-40

Platinum-based chemotherapeutic drugs such as cisplatin, carboplatin and oxaliplatin are widely applied for the treatment of various types of tumours. Over the last few decades, a large variety of Pt(II) and Pt(IV) complexes have been developed to improve the applicability in a wider spectrum of cancers, increase their therapeutic window and reduce the dose-limiting side effects. Photodynamic therapy (PDT), which is the administration of a photosensitiser followed by visible light activation, is a promising route to avoid damage to healthy cells and the surrounding tissue. Transition metal complexes as photochemotherapeutic agents are an attractive option for further development in the field of photoactivated chemotherapy (PACT). These complexes exhibit different numbers and types of excited states which are easily accessible upon light irradiation, subsequently giving rise to the formation of various photoproducts that can enable a distinct mode of action. Platinum-diazido complexes are promising candidates for PACT due to the low cytotoxicity when irradiated with visible light. This review summarises the mode of action of current platinum anticancer drugs with cisplatin as a lead example and the development of non-conventional Pt(II) complexes. Background information regarding PDT the photophysical and photochemical properties of metal complexes is provided, as well as notable examples of photoactivated metal complexes with biological activity. Particular emphasis is placed on recent developments on platinum photoactivated drugs.

(PDF emailed within 0-6 h: $19.90)

Accession: 055027569

Download citation: RISBibTeXText

PMID: 24800467

DOI: 10.3184/003685014X13904811808460

Related references

Trans-platinum complexes as anticancer drugs: recent developments and future prospects. Current Medicinal Chemistry 9(17): 1611-1618, 2002

Novel anticancer agents and targets: recent advances and future perspectives. Mini Reviews in Medicinal Chemistry 13(9): 1239-1255, 2014

Recent Advances in Platinum (IV) Complex-Based Delivery Systems to Improve Platinum (II) Anticancer Therapy. Medicinal Research Reviews 35(6): 1268-1299, 2016

Speciation of platinum compounds: A review of recent applications in studies of platinum anticancer drugs. Journal of Chromatography B 751(2): 205-211, 25 February, 2001

Recent developments in the field of anticancer platinum complexes. Recent Patents on Anti-Cancer Drug Discovery 1(2): 285-295, 2008

Recent advances in the field of anticancer activity of platinum complexes. Journal of Scientific & Industrial Research 46(1): 20-25, 1987

Overview: Recent Developments in Anticancer Agents. Expert Opinion on Therapeutic Patents 1(12): 1743-1764, 1991

Recent developments in ruthenium anticancer drugs. Metallomics 1(6): 458-470, 2011

The role of metallothionein, glutathione, glutathione S-transferases and DNA repair in resistance to platinum drugs in a series of L1210 cell lines made resistant to anticancer platinum agents. Biochemical Pharmacology 45(1): 253-256, 1993

New anticancer agents: recent developments in tumor therapy. Anticancer Research 32(7): 2999-3005, 2012

Recent advances in anticancer drugs. Idrugs 1(4): 408-411, 2008

The platinum market; recent history and future developments. Pages 13-20 1987, 1987

Recent developments in the pharmacology of anticancer drugs in the elderly. Current Opinion in Oncology 10(6): 572-579, 1998

Recent developments of C-4 substituted coumarin derivatives as anticancer agents. European Journal of Medicinal Chemistry 119: 141-168, 2017

Recent developments in the chemistry of plant-derived anticancer agents. Economic and medicinal plant research edited by H Wagner Hiroshi Hikino Norman R Farnsworth: 191, 1988